Barclays’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Barclays’s Portfolio HCAR Stock Details HCAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-334,398	Closed	-$3.32M	–	5502
2022 Q3	$3.32M	Buy	334,398 +34,242	+11%	+$339K	﹤0.01%	1408
2022 Q2	$2.95M	Sell	300,156 -19,117	-6%	-$188K	﹤0.01%	1608
2022 Q1	$3.13M	Buy	+319,273	New	+$3.12M	﹤0.01%	1523

Barclays's HCAR Position: Q4 2022 in Review

Barclays sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 334,398 shares — an estimated $3.32M sold.

Barclays first reported a position in HCAR in Q1 2022 and held it in 3 quarters. The position peaked at $3.32M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

Barclays reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Barclays sold 334,398 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $3.32M.
Barclays first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2022 and held it in 3 quarters.
Barclays's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $3.32M in Q3 2022.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.